Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases

  • Authors:
    • Tadashi Ohara
    • Tetsuo Morishita
    • Hiroshi Hashimoto
    • Masumi Akimoto
    • Yuhsaku Kanoh
    • Noriko Nakajima
    • Hidekazu Suzuki
    • Toshifumi Hibi
  • View Affiliations

  • Published online on: January 1, 2006     https://doi.org/10.3892/ijmm.17.1.53
  • Pages: 53-58
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The possible involvement of Toll-like receptor (TLR) genome DNA in the prolongation and relapse of inflammatory intestinal diseases and alcoholic hepatic diseases has been reported. In this study, we examined the relationship of mutations of the TLR 2, 4, 6 and 9 genomic DNA to recurrent or intractable gastritis or gastric ulcers. The subjects were 32 patients, including 6 with H. pylori (Hp)-positive gastritis, 4 with Hp-negative gastritis, 10 with Hp-positive tractable gastric ulcer, 5 with Hp-positive recurrent gastric ulcer after Hp eradication, and 7 with Hp-negative easily recurrent gastric ulcer after Hp eradication. Gastric mucosal tissue and peripheral blood specimens were collected from each of the patients. DNA was extracted from the tissue and blood specimens and subjected to electrophoresis by the PCR method, using the oligonucleotide primers of TLR 2, 4, 6 and 9. The gastric mucosal tissue specimens were collected endoscopically from the sites of the lesions. Subsequently, the presence or absence of genomic DNA mutations in the blood and tissue specimens was examined using a DNA sequencer. TLR 2, 4, 6 or 9 DNA mutations were not observed in any of the gastric mucosal or peripheral blood specimens obtained from patients with tractable gastritis or gastric ulcer, or from those with intractable gastric ulcer who were Hp-positive or Hp-negative or had become Hp-negative after eradication therapy. These data suggest that mutations of the TLR 2, 4, 6 and 9 genome DNA may not be involved in the recurrence, delayed healing or intractability of gastritis and gastric ulcers.

Related Articles

Journal Cover

January 2006
Volume 17 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ohara T, Morishita T, Hashimoto H, Akimoto M, Kanoh Y, Nakajima N, Suzuki H and Hibi T: Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases. Int J Mol Med 17: 53-58, 2006.
APA
Ohara, T., Morishita, T., Hashimoto, H., Akimoto, M., Kanoh, Y., Nakajima, N. ... Hibi, T. (2006). Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases. International Journal of Molecular Medicine, 17, 53-58. https://doi.org/10.3892/ijmm.17.1.53
MLA
Ohara, T., Morishita, T., Hashimoto, H., Akimoto, M., Kanoh, Y., Nakajima, N., Suzuki, H., Hibi, T."Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases". International Journal of Molecular Medicine 17.1 (2006): 53-58.
Chicago
Ohara, T., Morishita, T., Hashimoto, H., Akimoto, M., Kanoh, Y., Nakajima, N., Suzuki, H., Hibi, T."Analysis of Toll-like receptor 2, 4, 6 and 9 genome DNA mutations in patients with tractable and intractable gastric mucosal diseases". International Journal of Molecular Medicine 17, no. 1 (2006): 53-58. https://doi.org/10.3892/ijmm.17.1.53